Molzym is Part of Gradian Diagnostics
Molzym was founded in 2003 and headquarters in Bremen, Germany. They are a highly experienced 20-strong team of doctors, researchers, technicians and laboratory specialists, and their work covers solutions for molecular microbiology research and routine microbial pathogen diagnostics.
Prof. Michael Lorenz, founder of Molzym says: “I am delighted that Molzym will be joining Gradian Diagnostics. They share our values and hands-on, tailored approach to helping our customers achieve their aims. Being a leading microbial molecular diagnosis company we were keen to find trusted partners that we could collaborate with to deliver a full service, whilst also maintaining our focus. Being part of Gradian allows us to accelerate our growth and to set foot in the USA. Our customers will benefit, our staff will benefit, our current and new partners will benefit – a fantastic result all around.”
Alex Malbran, president of Gradian Diagnostics shares: “We are excited to have such an outstanding and esteemed company joining the group. Our ambition is to deliver best-in-class solutions that help hospitals and labs with the challenges and opportunities they face today and in the future. This could not be better served than with the brilliantly talented, and exceptional people at Molzym. It’s a privilege to have them on board and puts us in a position to improve molecular diagnosis for a broad range of customers.”
Gradian Diagnostics is based in Miami, USA. It is a holding company working on expanding diagnostic solutions by acquiring assets and companies with validated products around the world.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.